{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT00859781: Phase 2 Interventional Active, not recruiting Prostate Cancer
(2009)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03518073: Phase 2 Interventional Completed Alzheimer Disease (AD)
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03495323: Phase 1 Interventional Completed Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03579602: Phase 2/Phase 3 Interventional Completed Pediatric Central Nervous System Tumor
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04332653: Phase 1/Phase 2 Interventional Active, not recruiting Any Advanced Solid Tumors
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04477772: Phase 1 Interventional Completed Recurrent/Refractory Malignant Lymphoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sifarobocept [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04341116: Phase 2/Phase 3 Interventional Completed Coronavirus Disease 2019 COVID-19
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04165993: Phase 2 Interventional Active, not recruiting Metastatic Breast Cancer
(2019)
Source URL:
Class:
PROTEIN
